Key facts
- Robert F. Kennedy Jr.'s FDA plans to study the safety of mifepristone.
- Mifepristone has been available on the market for over 25 years.
- Approximately 7.5 million women have used the pill.
A report indicates that the Food and Drug Administration (FDA), under the leadership of Robert F. Kennedy Jr., intends to conduct a study on the safety of the abortion pill mifepristone. This proposed review comes despite the medication having been available on the market for more than 25 years. During this quarter-century, an estimated 7.5 million women have utilized the pill. The decision to re-evaluate the safety of a drug with such a long history of use has drawn attention.